ZymoGenetics offering $79 million in common stock
Biotechnology company ZymoGenetics Inc. said Thursday it is publicly offering about $79 million in common stock and boosting the number of shares, increasing the number it said it would offer.
ZymoGenetics said Friday it has sold a parcel of land next to its Eastlake headquarters for $11.5 million to a buyer apparently affiliated with Alexandria Real Estate Equities.